Assertio Holdings (ASRT) Return on Capital Employed (2020 - 2026)
Assertio Holdings' (ASRT) quarterly Return on Capital Employed came in at 18.15% in Q1 2026, up 314.0% year-on-year from 4.38% in Q1 2025, and down 39.73% quarter-over-quarter from 12.99% in Q4 2025.
Assertio Holdings (ASRT) Return on Capital Employed (2020 - 2026) Analysis & Trends
Assertio Holdings has disclosed Return on Capital Employed across 7 years of filings, most recently posting 18.15% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 18.15%, up 314.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 18.15% (up 314.0% YoY), and the FY2025 annual result was 14.52%, down 20.0% from the prior year.
- Return on Capital Employed came in at 18.15% for Q1 2026 at Assertio Holdings, down from 12.99% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 16.91% in Q2 2022 to a low of 142.45% in Q2 2024.
- The 5-year median for Return on Capital Employed is 17.9% (2025), against an average of 29.81%.
- Across the five-year window, Return on Capital Employed tumbled 15279 bps in 2024 and surged 11685 bps in 2025, its largest moves.
- Assertio Holdings' Return on Capital Employed stood at 14.42% in 2022, then sank by 804 bps to 101.57% in 2023, then surged by 85 bps to 14.77% in 2024, then rose by 12 bps to 12.99% in 2025, then slumped by 40 bps to 18.15% in 2026.
- The last three Return on Capital Employed figures came in at 18.15% (Q1 2026), 12.99% (Q4 2025), and 17.9% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | -18.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.15% |
| Dec 31, 2025 | -12.99% |
| Sep 30, 2025 | -17.90% |
| Jun 30, 2025 | -25.61% |
| Mar 31, 2025 | -21.29% |
| Dec 31, 2024 | -14.77% |
| Sep 30, 2024 | -23.10% |
| Jun 30, 2024 | -142.45% |
| Mar 31, 2024 | -131.69% |
| Dec 31, 2023 | -101.57% |
| Sep 30, 2023 | -72.07% |
| Jun 30, 2023 | 10.33% |
| Mar 31, 2023 | 10.17% |
| Dec 31, 2022 | 14.42% |
| Sep 30, 2022 | 15.96% |
| Jun 30, 2022 | 16.91% |
| Mar 31, 2022 | 6.93% |
| Dec 31, 2021 | 5.30% |
| Sep 30, 2021 | -15.43% |
| Jun 30, 2021 | -21.93% |